WE ENDEAVOR
To achieve the best quality standards in the pharmaceutical industry in India
OUR GROWTH DRIVERS
India is home to around 1.3 billion people or to put it differently, 1/7th of the world’s population. While this is a demographic advantage in many cases, the onus lies on the healthcare industry to maintain the health of the people
Supply-side Drivers
Cost advantage • Skilled manpower • India a major manufacturing hub • India accounts for 22 per cent of overall USFDA approved plants • Increasing penetration of chemists
Policy Support
National Health Policy 2015, which focuses on increasing public expenditure on healthcare segment • Reduction in approval time for new facilities • Plans to set up new pharmaceutical education and research institutes
Demand-side Drivers
Increasing fatal diseases • Accessibility of drugs to greatly improve • Increasing penetration of health insurance • Growing number of stress-related diseases due to change in lifestyle • Better diagnostic facilities
Glimpse of Our Future Endeavor
To develop at least 4 headquarters within one year (FY21-22) equipped with solid Research & Development and to put dedicated manpower for R&D to develop quality and affordable products.
Introduce Skincare and Ophthalmic and a New Drug Delivery System (Mouth dissolving strips) for the treatment of cold and cough and treatment of Thyroid.
Expansion of our Sales footprint in the Pharma division in the Domestic and Export markets.
Focus on Pharma and speciality divisions and Branded medicines through the launch of new products in the Gyeny, Chronic diseases, Gastrointestinal and Anti-allergic treatments. Increase our field force for Ethical marketing of drugs and medicines and to develop local distribution channel with the use of digital technology.
Our Products
Hard Hitting Anti-Bacterial & Antibiotic
